questionsmedicales.fr
Bactéries
Proteobacteria
Betaproteobacteria
Burkholderiales
Burkholderiaceae
Burkholderiaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections bactériennes
Diagnostic microbiologique
Polymerase Chain Reaction
Séquençage génétique
Symptômes
Infections bactériennes
Tests sérologiques
Infections bactériennes
Antibiogramme
Sensibilité aux antibiotiques
Symptômes
5
Symptômes
Infections bactériennes
Infections pulmonaires
Immunodépression
Infections cutanées
Traumatismes
Symptômes neurologiques
Infections bactériennes
Variabilité des symptômes
Infections bactériennes
Prévention
5
Prévention des infections
Hygiène
Vaccins
Prévention des infections
Surveillance médicale
Immunodépression
Hygiène hospitalière
Infections nosocomiales
Équipements de protection
Prévention des infections
Traitements
5
Antibiotiques
Infections bactériennes
Résistance aux antibiotiques
Infections bactériennes
Thérapies ciblées
Infections bactériennes
Prévention des infections
Immunodépression
Durée du traitement
Infections bactériennes
Complications
5
Complications
Infections bactériennes
Infections mortelles
Immunodépression
Complications neurologiques
Infections bactériennes
Hospitalisation
Infections bactériennes
Séquelles
Infections bactériennes
Facteurs de risque
5
Facteurs de risque
Immunodépression
Cysticfibrose
Infections bactériennes
Personnes âgées
Immunodépression
Travailleurs de la santé
Infections nosocomiales
Voyages
Infections bactériennes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Burkholderiaceae : Questions médicales les plus fréquentes",
"headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Burkholderiales",
"url": "https://questionsmedicales.fr/mesh/D000073556",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiales",
"code": {
"@type": "MedicalCode",
"code": "D000073556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia",
"alternateName": "Burkholderia",
"url": "https://questionsmedicales.fr/mesh/D019117",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia",
"code": {
"@type": "MedicalCode",
"code": "D019117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia complex",
"alternateName": "Burkholderia cepacia complex",
"url": "https://questionsmedicales.fr/mesh/D042602",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia complex",
"code": {
"@type": "MedicalCode",
"code": "D042602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia gladioli",
"alternateName": "Burkholderia gladioli",
"url": "https://questionsmedicales.fr/mesh/D042725",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia gladioli",
"code": {
"@type": "MedicalCode",
"code": "D042725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia mallei",
"alternateName": "Burkholderia mallei",
"url": "https://questionsmedicales.fr/mesh/D042726",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia mallei",
"code": {
"@type": "MedicalCode",
"code": "D042726",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.477"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia pseudomallei",
"alternateName": "Burkholderia pseudomallei",
"url": "https://questionsmedicales.fr/mesh/D016957",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia pseudomallei",
"code": {
"@type": "MedicalCode",
"code": "D016957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cupriavidus",
"alternateName": "Cupriavidus",
"url": "https://questionsmedicales.fr/mesh/D049921",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus",
"code": {
"@type": "MedicalCode",
"code": "D049921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cupriavidus necator",
"alternateName": "Cupriavidus necator",
"url": "https://questionsmedicales.fr/mesh/D020118",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus necator",
"code": {
"@type": "MedicalCode",
"code": "D020118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia",
"alternateName": "Ralstonia",
"url": "https://questionsmedicales.fr/mesh/D043367",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia",
"code": {
"@type": "MedicalCode",
"code": "D043367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ralstonia pickettii",
"alternateName": "Ralstonia pickettii",
"url": "https://questionsmedicales.fr/mesh/D049920",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia pickettii",
"code": {
"@type": "MedicalCode",
"code": "D049920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia solanacearum",
"alternateName": "Ralstonia solanacearum",
"url": "https://questionsmedicales.fr/mesh/D043368",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia solanacearum",
"code": {
"@type": "MedicalCode",
"code": "D043368",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae",
"alternateName": "Burkholderiaceae",
"code": {
"@type": "MedicalCode",
"code": "D042521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yusuke Takashima",
"url": "https://questionsmedicales.fr/author/Yusuke%20Takashima",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Yousuke Degawa",
"url": "https://questionsmedicales.fr/author/Yousuke%20Degawa",
"affiliation": {
"@type": "Organization",
"name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba."
}
},
{
"@type": "Person",
"name": "Tomoyasu Nishizawa",
"url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Hiroyuki Ohta",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Kazuhiko Narisawa",
"url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Collaborative Commentary for Understanding Communication Disorders.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37486768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_AJSLP-22-00385"
}
},
{
"@type": "ScholarlyArticle",
"name": "Communication experiences of healthcare students whilst managing adults with communication disorders.",
"datePublished": "2022-05-31",
"url": "https://questionsmedicales.fr/article/35695421",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/sajcd.v69i1.870"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Multivoice Chorus on Interpersonal Communication Disorder.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35854942",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6124778"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissemination Research in Communication Sciences and Disorders: A Tutorial.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36306509",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00421"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inequity in Peer Review in Communication Sciences and Disorders.",
"datePublished": "2022-06-27",
"url": "https://questionsmedicales.fr/article/35758875",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_AJSLP-21-00252"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Betaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020562"
},
{
"@type": "ListItem",
"position": 5,
"name": "Burkholderiales",
"item": "https://questionsmedicales.fr/mesh/D000073556"
},
{
"@type": "ListItem",
"position": 6,
"name": "Burkholderiaceae",
"item": "https://questionsmedicales.fr/mesh/D042521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Burkholderiaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Burkholderiaceae",
"description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Communication+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Burkholderiaceae",
"description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Communication+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Burkholderiaceae",
"description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Communication+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Burkholderiaceae",
"description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Communication+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Burkholderiaceae",
"description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Communication+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Burkholderiaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Communication+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Burkholderiaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Burkholderia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Burkholderia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes."
}
},
{
"@type": "Question",
"name": "Burkholderia peut-elle causer des infections cutanées ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de Burkholderia ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Burkholderia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène hospitalière sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Les équipements de protection individuelle sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour les infections par Burkholderia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles résistantes aux antibiotiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement antibiotique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Burkholderia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées."
}
},
{
"@type": "Question",
"name": "Quelles sont les séquelles possibles après une infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes."
}
},
{
"@type": "Question",
"name": "Les patients atteints de cysticfibrose sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils exposés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
The goal of the Collaborative Commentary (CC) system is to make the TalkBank adult clinical databases-including AphasiaBank, DementiaBank, RHDBank, and TBIBank-open to commentary and analysis from the...
CC allows a group leader to establish a commentary group and invite colleagues or students to join as members of the group. Members can then browse through the transcript database using the TalkBank B...
CC was released for public use in August 2022. It is being used currently in five research projects and eight classes. An important feature of CC is its ability to evaluate the reliability of coding s...
CC can contribute to a better understanding of connected speech features in aphasia, dementia, right hemisphere disorder, and traumatic brain injury. CC represents an extreme innovation not only for t...
Research has found that people with communication disabilities are three times more likely to encounter medical mishaps. Almost a third of patients with speech-language therapy (SLT) diagnoses have ot...
This study aims to describe the communication challenges and strategies employed by a group of final year Nursing, Medicine, Dietetics and Human Nutrition, Physiotherapy and Occupational Therapy stude...
A qualitative, phenomenological study design was used. Questionnaires were electronically distributed, and results were analysed thematically....
The most significant challenges whilst managing adults with communication disorders were patients' receptive and expressive language difficulties. Further challenges included lack of knowledge surroun...
This study revealed that there is a need to develop healthcare students' skills in managing adults with communication disorders. This is because of the challenges faced and inefficiency of the strateg...
As a type of music therapy, multipart chorus does not have high requirements for participants, and the basic level can be high or low. For college students, it is more likely to participate. Exploring...
Fifty college students in prison were selected as subjects and randomly divided into the control group and experimental group. The multivoice chorus method was used to conduct an intervention test on ...
The purpose of this tutorial is threefold: (a) to bring attention to the role and value of dissemination research in communication sciences and disorders (CSD), (b) to introduce a model that can be us...
This tutorial begins with a discussion of the role of dissemination in clinical research, with emphasis on differentiating the unique value of dissemination within the broader context of dissemination...
Dissemination research is an often overlooked but critical component of D&I efforts. When approached systematically and rigorously, dissemination can make meaningful contributions to clinical research...
The American Speech-Language-Hearing Association (ASHA) has committed to advancing diversity, equity, and inclusion (DEI) by retaining and advancing Black, Indigenous, and people of color (BIPOC) indi...
Inequity at the individual and systemic levels in peer review can harm BIPOC CSD authors. Such inequity has effects not limited to peer review itself and exerts long-term adverse effects on the recrui...
In recent years, the number of patients-particularly children-with autism spectrum disorder (ASD) has been continually increasing. ASD affects a child's language communication and social interaction t...
The third International Cognitive-Communication Disorders Conference was held in early 2022, providing an opportunity for researchers and clinicians to discuss management of cognitive-communication di...
Although there is a growing literature base that supports the inclusion of sociolinguistic methods, there remains a disconnect between the literature and clinical application that current researchers ...
https://doi.org/10.23641/asha.21614268....
Open science is a collection of practices that seek to improve the accessibility, transparency, and replicability of science. Although these practices have garnered interest in related fields, it rema...
An online survey was disseminated to researchers in the United States actively engaged in CSD research. Four-core open science practices were examined:...
Two hundred twenty-two participants met the inclusion criteria. Most participants were doctoral students (38%) or assistant professors (24%) at R1 institutions (58%). Participants reported low knowled...
Although participation in open science appears low in the field of CSD, participants expressed a strong desire to learn more in order to engage in these practices in the future. Supplemental Material ...
The aim of this study was to evaluate the Children's Communication Checklist-2 (CCC-2) for measuring social-pragmatic communication deficits and to ascertain their prevalence and functional impact in ...
We used parent and teacher responses to the CCC-2 to approximate inclusion (poor social-pragmatic skills) and exclusion (poor structural language skills or autistic symptomatology) criteria for social...
Regardless of the diagnostic algorithm used, the resulting prevalence rates for social-pragmatic deficits indicated that very few children had isolated social-communication difficulties (0-1.3%). Howe...
A considerable proportion of children in the early years of primary school has social-pragmatic deficits that interfere with behaviour and scholastic activity; however, these rarely occur in isolation...
There exists a dearth of research on the psychological experiences of childhood communication disorders. Caregivers of these children are one source who can provide us with this information since the ...
The article presents the reported experiences of six parental caregivers raising a child with a communication disorder within Johannesburg....
Data were collected via semi-structured interviews and underwent an interpretative phenomenological analysis....
Five themes are presented: feeling out of control; barriers to accessing services; caregivers left speechless; a misunderstood disability; and relinquishing control: 'I needed to be a mommy'....
The caregivers relayed an initially negative experience in raising a child with a communication disorder, marred with worry and fear for the future. In accessing services, they narrated their experien...
